Bariatric Surgery May Help Ease Urinary Incontinence

This article originally appeared here.
Share this content:
Bariatric Surgery May Help Ease Urinary Incontinence
Bariatric Surgery May Help Ease Urinary Incontinence

MONDAY, June 29, 2015 (HealthDay News) -- Bariatric surgery may also help ease urinary incontinence in the long term, a new study suggests. Results of the study were published online June 22 in JAMA Internal Medicine.

Two thousand people between the ages of 18 and 78 were recruited for the study. All had undergone bariatric surgery between 2005 and 2009. Their procedures were done at 10 different hospitals around the United States. Most of the participants -- 79 percent -- were women. About half of the women and more than one-fifth of the men reported having an episode of urinary incontinence at least once a week before they had surgery.

A significant weight loss -- 29 percent of body weight for women and 26 percent for men -- led to dramatic improvements in bladder control for most of the study's participants three years after bariatric surgery. The greater the weight loss, the greater their odds of improvement. The authors noted older participants or those with serious walking problems had less progress. Also, with every 10-pound weight gain, the risk of relapse increased.

"Our findings showing another important long-term benefit to bariatric surgery might help to motivate people who are severely overweight," study author Leslee Subak, M.D., of the University of California, San Francisco, said in a university news release. Subak is a professor in obstetrics, gynecology, and reproductive sciences, as well as urology and epidemiology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths